A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : G-CSF

Search Conditions:
Search Keyword : G-CSF
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: G-CSF
Appearance Frequency: 8148 time(s)
Long forms: 23

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
granulocyte colony-stimulating factor
(7900 times)
Hematology
(2193 times)
GM-CSF (885 times)
IL (345 times)
IL-3 (313 times)
1981 Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.
granulocyte CSF
(203 times)
Hematology
(81 times)
GM-CSF (155 times)
M-CSF (57 times)
IL-3 (44 times)
1985 Stimulation of multipotential, erythroid and other murine haematopoietic progenitor cells by adherent cell lines in the absence of detectable multi-CSF (IL-3).
granulocyte-macrophage colony-stimulating factor
(14 times)
Hematology
(4 times)
IL (3 times)
SCF (2 times)
ADRs (1 time)
1991 [GM-CSF and G-CSF: cytokines in clinical application].
growth factors
(8 times)
Neoplasms
(4 times)
CR (2 times)
Flu (2 times)
BM (1 time)
2001 Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
G-CSF group
(5 times)
Cardiology
(2 times)
5-HD (1 time)
EGFP (1 time)
ERK (1 time)
2006 Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice.
chemotherapy+granulocyte colony-stimulating factor
(1 time)
Transplantation
(1 time)
pCD34 (1 time)
2004 Effect of prior chemotherapy on hematopoietic stem cell mobilization.
CSF if FN strategy
(1 time)
Neoplasms
(1 time)
CFN (1 time)
FN (1 time)
SCLC (1 time)
1998 Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model.
G-colony stimulating factor
(1 time)
Gynecology
(1 time)
IL-6 (1 time)
PROM (1 time)
PTD (1 time)
2011 [Concentration of selected cytokines in women with premature rupture of membranes and preterm delivery--preliminary study].
G-CSF level was significantly decreased
(1 time)
General Surgery
(1 time)
MFH (1 time)
2007 Dedifferentiated liposarcoma with leukocytosis. A case report of G-CSF-producing soft-tissue tumors, possible association with undifferentiated liposarcoma lineage.
10  G-CSF loaded chitosan nanoparticles PCL/NP
(1 time)
Biomedical Engineering
(1 time)
PCL (1 time)
RP (1 time)
2017 G-CSF loaded nanofiber/nanoparticle composite coated with collagen promotes wound healing in vivo.
11  G-CSF treated mice expressed membrane type 1 matrix metalloprotease (MT1-MMP)
(1 time)
Clinical Medicine
(1 time)
CSF (1 time)
LDL (1 time)
M-CSF (1 time)
2014 Effects of G-CSF on serum cholesterol and development of atherosclerotic plaque in apolipoprotein E-deficient mice.
12  G-CSF vs no G-CSF
(1 time)
Drug Therapy
(1 time)
AML (1 time)
2012 Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
13  given before the septic insult
(1 time)
--- 2018 Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.
14  given in combination with vinblastine, doxorubicin, cisplatin, and filgrastim
(1 time)
Neoplasms
(1 time)
--- 1997 A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
15  given with high-dose doxorubicin (D) and filgrastim
(1 time)
Neoplasms
(1 time)
CDE (1 time)
1996 Dose escalation of high-dose cyclophosphamide and etoposide with high-dose doxorubicin (CDE) and filgrastim for poor-risk non-Hodgkin's lymphoma.
16  good response to colony stimulating factor
(1 time)
Internal Medicine
(1 time)
--- 1993 [Tenoxicam-induced agranulocytosis, with good response to colony stimulating factor (G-CSF)].
17  granulocyte/macrophage-colony-stimulating factor, granulocyte-stimulating factor
(1 time)
Allergy and Immunology
(1 time)
CsA (1 time)
IL-3 (1 time)
LTB4 (1 time)
1995 Immunosuppressive agents enhance the cytokine-induced priming of inflammatory cells.
18  granulocytopenic patients, adjunctive therapy with colony-stimulating factors
(1 time)
Pediatrics
(1 time)
CAS (1 time)
DAMB (1 time)
FLC (1 time)
2005 [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
19  granulokine colony-stimulating factor-primed
(1 time)
Transplantation
(1 time)
HDCT (1 time)
PBPC (1 time)
PBPCT (1 time)
1998 G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood.
20  growth factor use
(1 time)
Transplantation
(1 time)
ES (1 time)
2000 An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose.
21  growth factors have marketing approval in France: filgrastime
(1 time)
General Surgery
(1 time)
--- 2000 [Standards, options, and recommendations for the use of hematopoietic growth factors in oncology].
22  gynecologic malignancies but requires colony stimulating factor
(1 time)
Neoplasms
(1 time)
LVEF (1 time)
2001 Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors.
23  OBJECTIVEGranulocyte-colony stimulating factor
(1 time)
Neurosurgery
(1 time)
AIS (1 time)
ISNCSCI (1 time)
TSCIs (1 time)
2018 Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: a double-blind randomized controlled clinical trial.